Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/0L8 stock hub

FRA/0L8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/0L8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.1B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/0L8

In the news

Latest news · FRA/0L8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.5

P25 n/aP50 n/aP75 n/a

Trailing P/E21.2

P25 n/aP50 n/aP75 n/a

ROE23.5

P25 n/aP50 n/aP75 n/a

ROIC16.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/0L8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	1,193
Employees Change	-26%
Employees Change Percent	-3.12
Enterprise value	EUR 5.2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	In Vitro and In Vivo Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 5.1B
Price	EUR 79.9
Price currency	EUR
Rev Per Employee	1,124,057.15x
Sic	2835
Symbol	fra/0L8
Website	https://www.lantheus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.71%
EV Earnings	21.48x
EV/EBIT	20.99x
EV/EBITDA	16.74x
EV/Sales	3.96x
Forward P/E	16.49x
P/B ratio	4.89x
P/E ratio	21.23x
P/S ratio	3.83x
PE Ratio10 Y	97.47x
PE Ratio3 Y	32.92x
PE Ratio5 Y	46.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.85%
EBITDA Margin	23.64%
Gross margin	60.48%
Gross Profit	EUR 811.1M
Gross Profit Growth	-4.98%
Gross Profit Growth Q	-2.85%
Gross Profit Growth3 Y	13.12%
Gross Profit Growth5 Y	45.83%
Net Income	EUR 242M
Net Income Growth	9.72%
Net Income Growth Q	62.34%
Pretax Margin	24.17%
Profit Margin	18.05%
Profit Per Employee	EUR 202,853
ROA	8.28
Roa5y	7.5
ROCE	14.48
ROE	23.48
Roe5y	19.52
ROIC	16.5
Roic5y	20.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	46.03%
Cagr1y	11.85%
Cagr3y	-2.49%
Cagr5y	34.29%
EPS Growth	17.85
EPS Growth Q	76.47
Revenue Growth	0.62x
Revenue Growth Q	1.23x
Revenue Growth3 Y	14.61x
Revenue Growth5 Y	35.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.7
Assets	EUR 2B
Cash	EUR 432.4M
Current Assets	EUR 799M
Current Liabilities	EUR 282.5M
Debt	EUR 494.7M
Debt EBITDA	EUR 1.56
Debt Equity	EUR 0.47
Equity	EUR 1.1B
Interest Coverage	14.71
Liabilities	EUR 983.8M
Long Term Assets	EUR 1.2B
Long Term Liabilities	EUR 701.3M
Net Cash	EUR -62.3M
Net Cash By Market Cap	EUR -1.21
Net Debt EBITDA	EUR 0.2
Net Debt Equity	EUR 0.06
Tangible Book Value	EUR 231.4M
Tangible Book Value Per Share	EUR 3.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.83
Inventory Turnover	9.37
Net Working Capital	EUR 96.6M
Quick ratio	2.57
Working Capital	EUR 528.3M
Working Capital Turnover	EUR 1.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	6.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	4,307.06%
1Y total return	11.84%
200-day SMA	55.27
3Y total return	-7.29%
50-day SMA	68.01
50-day SMA vs 200-day SMA	50over200
5Y total return	336.61%
All Time High	114.3
All Time High Change	-30.1%
All Time High Date	2024-07-15
All Time Low	1.59
All Time Low Change	4,922%
All Time Low Date	2016-02-11
ATR	1.67
Ch YTD	41.37
High	79.9
High52	79.9
High52 Date	2026-05-08
High52ch	0%
Low	77.3
Low52	41.91
Low52 Date	2025-08-06
Low52ch	90.65%
Ma50ch	17.48%
Price vs 200-day SMA	44.58%
RSI	72.26
RSI Monthly	57.95
RSI Weekly	76.09
Sharpe ratio	0.41x
Sortino ratio	0.64
Total Return	6.91%
Tr YTD	41.37
Tr1m	22.36%
Tr1w	10.36%
Tr3m	47.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 252.8M
Operating Income Growth	-35.56
Operating Income Growth Q	-23.85
Operating Income Growth3 Y	42.88
Operating Income Growth5 Y	152.1
Operating margin	18.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58,431,220%
Shares Insiders	1.67%
Shares Institutions	100.7%
Shares Qo Q	-0.82%
Shares Yo Y	-6.91%
Short Ratio	5.26

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5.85x
Bv Per Share	16.24
Ch10y	4,307.1
Ch1m	22.36
Ch1w	10.36
Ch1y	11.84
Ch3m	47.58
Ch3y	-7.29
Ch5y	336.6
Ch6m	73.24
Change	9.6%
Change From Open	3.36
Close	72.9
Days Gap	6.04
Depreciation Amortization	62,746,220.1
Earnings Date	2026-05-07
EBIT	EUR 252.8M
EBITDA	EUR 317M
EPS	EUR 3.61
F Score	2
Fiscal Year End	December
Founded	1,956
Goodwill	203,001,254.8
Graham Number	37.21649
Graham Upside	-53.42
Income Tax	EUR 82.1M
Is Primary Listing	0
Last Earnings Date	2026-02-26
Last Report Date	2026-03-31
Ma150	57.38
Ma150ch	39.25%
Ma20	71.16
Ma20ch	12.28%
Open	77.3
Position In Range	100
Ppne	133,607,436.6
Price Date	2026-05-08
Price EBITDA	EUR 16.21
Ptbv Ratio	22.2
Relative Volume	6.49x
Revenue	1,341,000,179x
Tax By Revenue	6.12x
Tax Rate	25.33%
Tr6m	73.24%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/0L8 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/0L8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/0L8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+100.7%

Share of float held by funds and institutions

Insider ownership

+1.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/0L8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

72.3

Above 70: short-term overbought

Price vs 200-day MA

+44.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.41

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/0L8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/0L8 stock rating?

fra/0L8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/0L8 analysis?

The full report lives at /stocks/fra/0L8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/0L8?

The latest report frames fra/0L8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/0L8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.